Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Gold Miners ETF (GDX) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

VanEck Gold Miners ETFTrade
Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

VanEck Gold Miners ETF vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? VanEck Gold Miners ETF trades at $84.01 (market cap $26.33B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: VanEck Gold Miners ETF is far larger — about 3.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and VanEck Gold Miners ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Gold Miners ETF for 77 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

GDXIONS
Market Cap
$26.33B$7.04B
Volume
15,141,5462,977,440
52-Week High
$115.84$86.50
52-Week Low
$68.28$42.38
Typical Hold Time
77 Days0 Days
Sector
—Health
Enterprise Value
—$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Gold Miners ETF

GDX trades at $87.24, down 1.46% on the day, with technical indicators showing a neutral to bearish bias amid mixed signals from moving averages and oscillators. The ETF's fundamental metrics are not provided in the snapshot, but recent news highlights ongoing institutional repositioning and comparisons between gold miners and physical gold. Support and resistance levels are tightly clustered around the current price, suggesting near-term consolidation.

The outlook for GDX hinges on gold price trends and interest rate movements, with potential upside from inflation hedging demand but risks from institutional selling and metal volatility. Investors face a balanced risk-reward scenario given neutral sentiment and lack of clear directional catalysts.

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GDX
44% Buy56% Sell
Avg holding period · 77 Days
IONS
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About VanEck Gold Miners ETF

The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.

Read more on GDX →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →